Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Deferring a nasogastric tube in non-operatively managed small bowel obstruction

Official title: The Effect of Nasogastric Tube Placement on Complications in Patients With Small Bowel Obstruction - the SBO-TUBE Randomized Controlled Trial

Run by University Hospital, Linkoeping · NCT07574515 · Data updated 2026-11-12

This trial tests whether not placing a nasogastric tube in patients with small bowel obstruction who are not having immediate surgery can reduce respiratory complications.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorUniversity Hospital, Linkoeping
Academic / other
Locations3 sites (Linköping and 2 other locations)
StatusRecruiting
StartedMay 27, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedJune 11, 2026
Trial IDNCT07574515 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults diagnosed with small bowel obstruction by CT who are planned for non-operative management and do not have an NGT placed, among other criteria.

Probably not a fit

Patients with obstructions who benefit from early NGT placement or who have conditions excluded from the trial may not experience any improvement.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, open-label study compares two management strategies for non-operatively treated small bowel obstruction: deferring nasogastric tube placement versus placing it. The goal is to see if delaying the NGT lowers respiratory complications such as pneumonia. Eligible participants have SBO diagnosed by CT and do not require urgent surgery. Exclusions include existing NGT, several neurologic conditions, dysphagia with prior stroke, and signs of pneumonia at baseline. Conducted at Linköping University Hospital and collaborating centers in Motala and Värnamo, Sweden, the trial aims to clarify best-practice for minimizing complications in SBO care.

Why it matters

Potential benefit: If successful, patients may have fewer respiratory complications and a simpler non-operative care pathway.

How similar studies have gone: Observational data have suggested higher pneumonia risk with NGT use, but randomized evidence in SBO is limited, making this a pioneering approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Small bowel obstruction diagnosed on Computer Tomography

Exclusion Criteria:

* Nasogastric Tube already places
* Amyotrophic lateral sclerosis
* Cerebral palsy
* Dementia
* Parkinson's disease
* Multiple Sclerosis
* Previous stroke with documented persistent dysphagia
* Planned for urgent surgery
* Acute Massive Gastric Dilatation
* Gastric outlet obstruction
* Fundoplicatio/Inability to vomit
* Signs of pneumonia/pneumonitis on initial diagnostic CT

Where it's running

  • Linköping University Hospital
    Linköping, Sweden
    Recruiting
  • Motala Lasarett
    Motala, Sweden
    Recruiting
  • Värnamo Lasarett
    Värnamo, Sweden
    Recruiting

Study contacts

  • Principal investigator: Jens Wretborn, Associate Professor — Clinical Department of Emergency Medicine in Linköping, Region Östergötland, Linköping, Sweden; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
  • Study coordinator: Jens Wretborn, Associate Professor
  • Email: jens.wretborn@liu.se
  • Phone: +46101030000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.